Infectious Disease Connect Expands Telemedicine Services
April 16 2024 - 9:15AM
Infectious Disease Connect (ID Connect), a leading infectious
diseases telemedicine and software solutions company, has expanded
its services to meet growing demand. The company now offers two
cutting-edge service lines — pediatric infectious diseases
telemedicine (tele-ID) and tele-Outpatient Parenteral Antimicrobial
Therapy (tele-OPAT).
Addressing the problem of access to pediatric infectious
diseases care, ID Connect's pediatric tele-ID service provides
right-sized, top-quality pediatric ID care to hospitals and health
systems via telemedicine. The company currently provides pediatric
tele-ID services to 10 of its over 80 hospital partners.
“Through pediatric tele-ID, our mission is to enhance access to
world-class pediatric infectious diseases experts,” said Rima Abdel
Massih, M.D., Co-Founder and Chief Executive Officer, ID Connect.
“The transformative impact on patient care is evident. Without our
services, one hospital would have resorted to transferring
approximately 30% of their pediatric infectious diseases cases. By
enabling patients and their families to remain within their
communities, we can provide timely care and improve outcomes for
patients, families, and hospitals.”
In addition to pediatric tele-ID, ID Connect is at the forefront
of delivering patient-centric, comprehensive continuity of care
post-hospital discharge in patients receiving parenteral
antimicrobials. This groundbreaking tele-OPAT program ensures a
safe transition of care through proactive monitoring and management
of patients in the outpatient setting. The remote OPAT team
consists of infectious diseases physicians, pharmacists, and nurses
that work collaboratively with the onsite discharging team, case
managers, infusion companies, and home health agencies.
“Our tele-OPAT program is designed to ensure patient safety
post-discharge. The proactive monitoring of patients through such
programs is proven to reduce readmission rates, drug related side
effects and overall costs of care,” said Dr. Abdel Massih. “Our
mission at ID Connect is to fill the gaps in infectious diseases
care with innovative solutions such as pediatric tele-ID and
tele-OPAT, focusing on improving patient safety and outcomes
in communities in need of access to ID expertise.”
###
About Infectious Disease Connect
ID Connect is a world leader in telemedicine-enabled care of
infectious diseases, antimicrobial stewardship, and infection
control and prevention. It is the only telemedicine company
focusing on infectious diseases that offers services provided by
academic faculty (UPMC and University of Pittsburgh School of
Medicine). The company’s technology, precision medicine, and data
science are paired with world-class infectious diseases physicians
and pharmacists to effectively manage infectious diseases across
the U.S. At ID Connect, we strive to provide access to top quality
infectious diseases care, improve patient outcomes, and reduce the
impact of infectious diseases on communities. For more information,
go to IDCtelemed.com.
Chelsey Rovesti
Infectious Disease Connect
833-271-2408
media@idctelemed.com